StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage Zero is down 99.95% in one year! FACTS

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Oct 13, 2022 11:34am

84 Views

Post# 35022381

RE:RE:RE:RE:Stage Zero is down 99.95% in one year! FACTS

Don't wait something from them they have no clue at all

They're like JHT and his team

You bring absolutely nothing to the table. | Friendship Ecard

Liked2Think wrote: Again, how much money has the aristotle test generated Stagezero?

Your implying these "poop in a box" people are buying up companies because they know their "poop in a box" way of testing is dying out and they need something that makes them money.

Kind of like how Stagezero knew they made no money besides covid testing and bought out CARE that generated $1M per quarter before the companies were merged and now after the merger generates in total $1M per quarter.

If "poop in a box" thinks their tests are going the way of the dodo bird then why dont they buy out Stagezero? Stage has the "superior" test after all?

How much has that test made them though?

Maybe 8 cents a share is too rich for "poop in the box" company.